Leg wraps may help heart failure patients shed fluid faster
NCT ID NCT06418932
First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times
Summary
This study tested whether adding leg compression to standard diuretic treatment helps people hospitalized with heart failure and severe fluid buildup. 106 adults received either diuretics alone or diuretics plus leg compression for up to 72 hours. Researchers measured changes in urine sodium, weight, leg swelling, and congestion scores to see if compression improves fluid removal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
106 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or older. * Patient with clinical judgment of acute decompensated heart failure in the first 96 hours from the start of parenteral diuretic treatment. * Patient treated with furosemide at least 40 mg in the last 24 hours. * NT-proBNP levels\>1000 pg/ml at least 1 time since the onset of decompensation. * Presence of tibio-malleolar edema at least grade II/IV at the time of inclusion. * Inferior vena cava (IVC) diameter on ultrasonography ≤21 mm at the time of the "screening" visit. Exclusion Criteria: * Being admitted to the Intensive Care Unit. * Renal transplant, chronic renal failure stage 5 (eGFR \<15 ml/min/1.73m2) or being included in dialysis program (peritoneal/hemodialysis) or in need of ultrafiltration. * Absence of peripheral pulses. * Ankle brachial index (ABI) \<0.9. * History of severe peripheral artery disease. * Previous intolerance to compressive bandaging. * HF secondary to acute myocardial infarction.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute decompensated heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, 30120, Spain
-
Hospital Clínico Universitario de Valencia
Valencia, Spain
-
Hospital General de Valencia
Valencia, 46014, Spain
-
Hospital Puerta de Hierro
Madrid, 28222, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario de Torrevieja
Torrevieja, Alicante, 03186, Spain
-
Hospital de Denia
Denia, Alicante, 03700, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Stick-On patch aims to catch dangerous heart decline sooner
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?